Optimum radiation dose for palliation in head and neck squamous cell carcinoma (OpRAH) - A phase 3 randomized controlled trial.
Mallick S, Dagar A, Ghosh A, Aashita, Raj J, Hazarika S, Meena JK, Kumar A, Sharma J, Panda S, Sharma A, Singh M, Sharma D, Thakar A.
Mallick S, et al. Among authors: meena jk.
Radiother Oncol. 2024 Nov 8;202:110611. doi: 10.1016/j.radonc.2024.110611. Online ahead of print.
Radiother Oncol. 2024.
PMID: 39522825